Annexe 6. PLM scale (Paris-North, Lille and Montpellier Scale) (d'après, 2014. ,
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement, 2011. ,
Focal cortical presentations of Alzheimer's disease. Brain, pp.2636-2681, 2007. ,
Posterior cortical atrophy and Alzheimer???s disease: a meta-analytic review of neuropsychological and brain morphometry studies, Brain Imaging and Behavior, vol.2012, issue.7, 2013. ,
DOI : 10.1007/s11682-013-9236-1
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein, Proceedings of the National Academy of Sciences, vol.102, issue.38, pp.13461-13467, 2005. ,
DOI : 10.1073/pnas.0503689102
Criteria for the diagnosis of corticobasal degeneration, Neurology, vol.80, issue.5, pp.496-503, 2013. ,
DOI : 10.1212/WNL.0b013e31827f0fd1
Tau and ??-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs, Acta Neuropathologica, vol.60, issue.230, pp.53-62, 2007. ,
DOI : 10.1007/s00401-006-0146-9
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment, J Alzheimers Dis, vol.40, issue.4, pp.919-946, 2014. ,
Added diagnostic value of CSF biomarkers in differential dementia diagnosis, Neurobiology of Aging, vol.31, issue.11, pp.1867-76, 2010. ,
DOI : 10.1016/j.neurobiolaging.2008.10.017
Early neuropsychological detection of Alzheimer's disease, European Journal of Clinical Nutrition, vol.38, issue.11, 2014. ,
DOI : 10.2174/156720511797633160
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease, New England Journal of Medicine, vol.367, issue.9, pp.795-804, 2012. ,
DOI : 10.1056/NEJMoa1202753
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.110, issue.47, pp.4502-4511, 2013. ,
DOI : 10.1073/pnas.1317918110
Amyloid-?? and Tau, JAMA Neurology, vol.71, issue.4, p.2014 ,
DOI : 10.1001/jamaneurol.2013.5847
The New Classification of Primary Progressive Aphasia into Semantic, Logopenic, or Nonfluent/Agrammatic Variants, Current Neurology and Neuroscience Reports, vol.68, issue.Pt 7, pp.484-90, 2010. ,
DOI : 10.1007/s11910-010-0140-4
CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.8, pp.834-842, 2011. ,
DOI : 10.1136/jnnp.2010.221853
Posterior Cortical Atrophy: Review of the Recent Literature, Current Neurology and Neuroscience Reports, vol.55, issue.12, 2013. ,
DOI : 10.1007/s11910-013-0406-8
White matter hyperintensities and cognition: Testing the reserve hypothesis, Neurobiology of Aging, vol.32, issue.9, pp.1588-98, 2011. ,
DOI : 10.1016/j.neurobiolaging.2009.10.013
The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs, Neurology, vol.64, issue.8, pp.1397-403, 2005. ,
DOI : 10.1212/01.WNL.0000158423.05224.7F
The role of the immune system in clearance of Abeta from the brain, Brain Pathol, 2008. ,
Neuropathological stageing of Alzheimer-related changes, Acta Neuropathologica, vol.80, issue.4, pp.239-259, 1991. ,
DOI : 10.1007/BF00308809
Early-Onset Alzheimer Disease in Families With Late-Onset Alzheimer Disease, Archives of Neurology, vol.63, issue.9, pp.1307-1318, 2006. ,
DOI : 10.1001/archneur.63.9.1307
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses, Alzheimer's & Dementia, vol.6, issue.2, 2010. ,
DOI : 10.1016/j.jalz.2009.12.005
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells., Proceedings of the National Academy of Sciences, vol.90, issue.5, pp.2092-2098, 1993. ,
DOI : 10.1073/pnas.90.5.2092
Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum, The American Journal of Human Genetics, vol.65, issue.3, pp.664-670, 1999. ,
DOI : 10.1086/302553
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain, 2016. ,
Pittsburgh compound B retention and progression of cognitive status - a meta-analysis, European Journal of Neurology, vol.31, issue.8, pp.1060-1067, 2014. ,
DOI : 10.1111/ene.12398
Mini-Mental State Examination (MMSE), Psychopharmacol Bull, vol.24, issue.4, pp.689-92, 1988. ,
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity, Annals of Neurology, vol.39, issue.5, pp.457-64, 1990. ,
DOI : 10.1002/ana.410270502
Molecular genetics of early-onset Alzheimer's disease revisited, Alzheimer's & Dementia, vol.12, issue.6 ,
DOI : 10.1016/j.jalz.2016.01.012
Human apoE Isoforms Differentially Regulate Brain Amyloid-?? Peptide Clearance, Science Translational Medicine, vol.3, issue.89, pp.89-57, 2011. ,
DOI : 10.1126/scitranslmed.3002156
Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation, J. Alzheimers Dis. JAD, vol.19, pp.465-480, 2010. ,
Type 2 Diabetes and Late-Onset Alzheimer???s Disease, Dementia and Geriatric Cognitive Disorders, vol.31, issue.6, pp.424-430, 2011. ,
DOI : 10.1159/000324134
Prevalence and severity of microbleeds in a memory clinic setting, Neurology, vol.66, issue.9, pp.1356-60, 2006. ,
DOI : 10.1212/01.wnl.0000210535.20297.ae
Posterior cortical atrophy, The Lancet Neurology, vol.11, issue.2, pp.170-178 ,
DOI : 10.1016/S1474-4422(11)70289-7
URL : https://hal.archives-ouvertes.fr/hal-01289466
Pathogenic SORL1 mutations andparkinsonian features in Alzheimer's disease. AAIC P1-226, 2016. ,
Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system, Neuroscience & Biobehavioral Reviews, vol.68, pp.547-562, 2016. ,
DOI : 10.1016/j.neubiorev.2016.06.014
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, pp.245-56, 2011. ,
Prediction of pathology in primary progressive language and speech disorders, Neurology, vol.74, issue.1, pp.42-51, 2010. ,
DOI : 10.1212/WNL.0b013e3181c7198e
Screening for predementia AD: Time-dependent operating characteristics of episodic memory tests, Neurology, vol.80, issue.14, pp.1307-1321, 2013. ,
DOI : 10.1212/WNL.0b013e31828ab2c9
Good gene, bad gene: New APP variant may be both, Progress in Neurobiology, vol.99, issue.3, pp.281-92, 2012. ,
DOI : 10.1016/j.pneurobio.2012.06.004
Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease, Journal of Neuroscience, vol.28, issue.48, pp.12877-86, 2008. ,
DOI : 10.1523/JNEUROSCI.4582-08.2008
The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects, Frontiers in Aging Neuroscience, vol.5, p.47, 2013. ,
DOI : 10.3389/fnagi.2013.00047
The 5 words " : a simple and sensitive test for the diagnosis of Alzheimer's disease]. Presse Médicale Paris Fr, pp.31-1696, 1983. ,
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, The Lancet Neurology, vol.13, issue.6, pp.614-643 ,
DOI : 10.1016/S1474-4422(14)70090-0
The cerebrospinal fluidAlzheimer profile": easily said, but what does it mean? Alzheimers Dement, pp.713-723, 2014. ,
De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group., Journal of Medical Genetics, vol.35, issue.8, pp.672-675, 1998. ,
DOI : 10.1136/jmg.35.8.672
Distinct Functions for Anterograde and Retrograde Sorting of SORLA in Amyloidogenic Processes in the Brain, Journal of Neuroscience, vol.35, issue.37, pp.12703-12716, 2015. ,
DOI : 10.1523/JNEUROSCI.0427-15.2015
Classification and basic pathology of Alzheimer disease, Acta Neuropathologica, vol.14, issue.2, pp.5-36, 2009. ,
DOI : 10.1007/s00401-009-0532-1
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia, Neurobiology of Aging, vol.29, issue.8, pp.1143-59, 2008. ,
DOI : 10.1016/j.neurobiolaging.2007.02.016
Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications, Neurodegener Dis, vol.5, pp.3-4190, 2008. ,
Vascular cognitive impairment in dementia, Maturitas, vol.79, issue.2, pp.220-226, 2014. ,
DOI : 10.1016/j.maturitas.2014.06.004
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA: The Journal of the American Medical Association, vol.278, issue.16, pp.1349-56, 1997. ,
DOI : 10.1001/jama.278.16.1349
Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease????Yes, Archives of Neurology, vol.55, issue.5, pp.740-741, 1998. ,
DOI : 10.1001/archneur.55.5.740
Seizures and Epilepsy in Alzheimer's Disease, CNS Neuroscience & Therapeutics, vol.21, issue.Suppl 1, 2012. ,
DOI : 10.1111/j.1755-5949.2011.00251.x
The effect of white matter lesions on cognition in the elderly???small but detectable, Nature Clinical Practice Neurology, vol.33, issue.11, pp.620-627, 2007. ,
DOI : 10.1038/ncpneuro0638
Rapport sur la maladie d'Alzheimer et les maladies apparentées. Paris : Office parlementaire d'évaluation des politiques de santé, 2005. ,
Incidence and subtypes of early-onset dementia in a geographically defined general population, Neurology, vol.75, issue.14, pp.1249-55, 2010. ,
DOI : 10.1212/WNL.0b013e3181f5d4c4
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry, pp.903-910, 2011. ,
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochemical and Biophysical Research Communications, vol.120, issue.3, pp.534-543, 1984. ,
DOI : 10.1016/S0006-291X(84)80190-4
Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene, Experimental Neurology, vol.208, issue.2, pp.264-272, 2007. ,
DOI : 10.1016/j.expneurol.2007.08.016
Cognition and anatomy in three variants of primary progressive aphasia, Annals of Neurology, vol.60, issue.3, pp.335-381, 2004. ,
DOI : 10.1002/ana.10825
Classification of primary progressive aphasia and its variants, Neurology, vol.76, issue.11, pp.1006-1020, 2011. ,
DOI : 10.1212/WNL.0b013e31821103e6
Screening for dementia by memory testing, Neurology, vol.38, issue.6, pp.900-903, 1988. ,
DOI : 10.1212/WNL.38.6.900
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease, Neurobiology of Aging, vol.28, issue.3, 2007. ,
DOI : 10.1016/j.neurobiolaging.2006.02.007
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP, Neurobiology of Aging, vol.31, issue.5, 2010. ,
DOI : 10.1016/j.neurobiolaging.2008.06.012
Variants in Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.117-144, 2013. ,
DOI : 10.1056/NEJMoa1211851
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain, Neuroscience, vol.143, issue.2, pp.461-75, 2006. ,
DOI : 10.1016/j.neuroscience.2006.08.027
INTRAFAMILIAL DIVERSITY OF PHENOTYPE ASSOCIATED WITH APP DUPLICATION, Neurology, vol.71, issue.23, pp.1925-1931, 2008. ,
DOI : 10.1212/01.wnl.0000339400.64213.56
URL : https://hal.archives-ouvertes.fr/hal-00482227
Amyloid ??-peptide is produced by cultured cells during normal metabolism, Nature, vol.359, issue.6393, pp.322-327, 1992. ,
DOI : 10.1038/359322a0
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid ??-peptide, Nature Reviews Molecular Cell Biology, vol.26, issue.2, pp.101-113, 2007. ,
DOI : 10.1038/nrm2101
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study, The Lancet Neurology, vol.5, issue.3, pp.228-34293, 2006. ,
DOI : 10.1016/S1474-4422(06)70355-6
The Alzheimer family of diseases: Many etiologies, one pathogenesis?, Proceedings of the National Academy of Sciences, vol.94, issue.6, pp.2095-2102, 1997. ,
DOI : 10.1073/pnas.94.6.2095
The prevalence and causes of dementia in people under the age of 65 years, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.9, pp.1206-1215, 2003. ,
DOI : 10.1136/jnnp.74.9.1206
The corticobasal syndrome???Alzheimer???s disease conundrum, Expert Review of Neurotherapeutics, vol.11, issue.11, pp.1569-78, 2011. ,
DOI : 10.1586/ern.11.153
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome, Movement Disorders, vol.68, issue.Part 10, pp.1375-1384, 2009. ,
DOI : 10.1002/mds.22574
Incidence of New-Onset Seizures in Mild to Moderate Alzheimer Disease, Archives of Neurology, vol.69, issue.3, pp.368-372, 2012. ,
DOI : 10.1001/archneurol.2011.830
Suspected non-Alzheimer disease pathophysiology ??? concept and controversy, Nature Reviews Neurology, vol.33, issue.2, pp.117-141, 2016. ,
DOI : 10.1038/nrneurol.2015.251
Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease, Archives of Neurology, vol.56, issue.10, pp.1233-1242, 1999. ,
DOI : 10.1001/archneur.56.10.1233
A mutation in APP protects against Alzheimer???s disease and age-related cognitive decline, Nature, vol.43, issue.7409, pp.96-105, 2012. ,
DOI : 10.1038/nature11283
Associated with the Risk of Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.107-123, 2013. ,
DOI : 10.1056/NEJMoa1211103
The Natural History of Alzheimer's Disease: A Brain Bank Study, Journal of the American Geriatrics Society, vol.51, issue.suppl l, 1995. ,
DOI : 10.1111/j.1532-5415.1995.tb07401.x
Variable phenotype of Alzheimer's disease with spastic paraparesis, J Neurochem. Feb, vol.104, issue.3, pp.573-83, 2008. ,
Amyloid imaging as a biomarker for cerebral ??-amyloidosis and risk prediction for Alzheimer dementia, Neurobiology of Aging, vol.32, issue.1, pp.20-36, 2011. ,
DOI : 10.1016/j.neurobiolaging.2011.09.006
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, vol.56, issue.9, pp.1143-53, 2001. ,
DOI : 10.1212/WNL.56.9.1143
Early-versus late-onset Alzheimer's disease: more than age alone, J Alzheimers Dis, vol.19, issue.4, pp.1401-1409, 2010. ,
Estimating the burden of early onset dementia; systematic review of disease prevalence, European Journal of Neurology, vol.40, issue.Pt 9, pp.563-572 ,
DOI : 10.1111/ene.12325
Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update, J Alzheimers Dis, vol.17, issue.2, pp.259-65, 2009. ,
Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships, J Alzheimers Dis, vol.37, issue.4, pp.653-662, 2013. ,
A diagnostic scale for Alzheimer???s disease based on cerebrospinal fluid biomarker profiles, Alzheimer's Research & Therapy, vol.6, issue.3, p.38, 2014. ,
DOI : 10.1186/alzrt267
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis, Alzheimer's & Dementia, vol.10, issue.5, pp.390-394, 2014. ,
DOI : 10.1016/j.jalz.2013.06.008
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease, Neurology, vol.56, issue.1, pp.127-136, 2001. ,
DOI : 10.1212/WNL.56.1.127
Diagnostic criteria for corticobasal syndrome: a comparative study, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.4, pp.405-415 ,
DOI : 10.1136/jnnp-2011-300875
Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes, Journal of Neurology, vol.84, issue.6, pp.1463-72 ,
DOI : 10.1007/s00415-015-7738-z
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, pp.939-983, 1984. ,
DOI : 10.1212/WNL.34.7.939
Et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, pp.263-272, 2011. ,
The cognitive profile of posterior cortical atrophy, Neurology Feb, vol.1466, issue.3, pp.331-339, 2006. ,
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia, Brain, vol.137, issue.4, pp.1176-92 ,
DOI : 10.1093/brain/awu024
The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer???s Disease: The Temporal Emergence of Cognitive Decline, Journal of Alzheimer's Disease, vol.48, issue.4, pp.1095-107, 2015. ,
DOI : 10.3233/JAD-150137
Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease, European Journal of Nuclear Medicine and Molecular Imaging, vol.11, issue.Suppl 2, pp.486-510, 2005. ,
DOI : 10.1007/s00259-005-1762-7
The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.11, 2003. ,
DOI : 10.1136/jnnp.74.11.1521
Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons, European Journal of Human Genetics, vol.39, issue.5, pp.710-716, 2016. ,
DOI : 10.1007/s00415-013-7160-3
URL : https://hal.archives-ouvertes.fr/hal-01431285
CNR-MAJ collaborators. SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease. Mol Psychiatry, pp.831-837, 2016. ,
The behavioural/dysexecutive variant of Alzheimer???s disease: clinical, neuroimaging and pathological features, Brain, vol.138, issue.9, pp.2732-2781, 2015. ,
DOI : 10.1093/brain/awv191
Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Hum Brain Mapp, pp.4421-4458, 2015. ,
Seizures in Alzheimer disease: clinical and epidemiological data. Epilepsy Curr, 2012. ,
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes, J Alzheimers Dis, vol.31, issue.1, pp.13-20, 2012. ,
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton, J Neurosci, vol.11, issue.6, pp.1748-55, 1991. ,
Brain atrophy in Alzheimer???s Disease and aging, Ageing Research Reviews, vol.30, issue.16, pp.1568-163730002, 2016. ,
DOI : 10.1016/j.arr.2016.01.002
Amyloid-? protein precursor gene expression in alzheimer's disease and other conditions, J Alzheimers Dis, vol.28, pp.561-566, 2012. ,
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease, Molecular Psychiatry, vol.17, issue.9, pp.875-884, 2012. ,
DOI : 10.1093/hmg/ddq390
URL : https://hal.archives-ouvertes.fr/hal-00965204
Alzheimer's Disease, New England Journal of Medicine, vol.362, issue.4, pp.329-373, 2010. ,
DOI : 10.1056/NEJMra0909142
PET imaging of brain amyloid in dementia: a review, International Journal of Geriatric Psychiatry, vol.46, issue.(Suppl 2), pp.991-1000, 2011. ,
DOI : 10.1002/gps.2640
Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease, Archives of Neurology, vol.68, issue.1, pp.99-106, 2011. ,
DOI : 10.1001/archneurol.2010.346
Progressive posterior cortical dysfunction: A clinicopathologic series, Neurology, vol.63, issue.7, pp.1175-80, 2004. ,
DOI : 10.1212/01.WNL.0000140290.80962.BF
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease, Nature Genetics, vol.279, issue.2, pp.168-77, 2007. ,
DOI : 10.1038/ng1943
Are there susceptibility factors for primary progressive aphasia? Brain Lang, pp.135-143, 2013. ,
Vascular dementia: diagnostic criteria for research studies, 1993. ,
Genomics of Alzheimer Disease, JAMA Neurology, vol.73, issue.7, pp.867-74, 2016. ,
DOI : 10.1001/jamaneurol.2016.0301
Factors that influence survival in a probable Alzheimer disease cohort, Alzheimer's Research & Therapy, vol.4, issue.3, p.16, 2012. ,
DOI : 10.1186/alzrt119
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nature Genetics, vol.302, issue.1, 2006. ,
DOI : 10.1038/ng1718
De novo deleterious genetic variations target a biological network centered on A?? peptide in early-onset Alzheimer disease, Molecular Psychiatry, vol.42, issue.9, pp.1046-56, 2015. ,
DOI : 10.1038/mp.2015.100
Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study, Neurology, vol.69, issue.19, pp.1859-67, 2007. ,
DOI : 10.1212/01.wnl.0000279336.36610.f7
URL : https://hal.archives-ouvertes.fr/inserm-00169640
The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study, J Alzheimers Dis, vol.22, issue.1, pp.285-94, 2010. ,
Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert, Acta Neuropathologica, vol.100, issue.3, pp.259-69, 2000. ,
DOI : 10.1007/s004019900178
Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease, Archives of Neurology, vol.62, issue.10, pp.1601-1609, 2005. ,
DOI : 10.1001/archneur.62.10.1601
Seizures in Alzheimer Disease, Archives of Neurology, vol.66, issue.8, pp.992-999, 2009. ,
DOI : 10.1001/archneurol.2009.130
Synapse loss in the temporal lobe in Alzheimer's disease, Annals of Neurology, vol.192, issue.2, pp.190-199, 1993. ,
DOI : 10.1002/ana.410330209
Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus, J Alzheimers Dis, vol.9, issue.3, pp.101-116, 2006. ,
The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis, Journal of Neurology, Neurosurgery & Psychiatry, vol.39, issue.(19 Pt 2), pp.235-278, 2016. ,
DOI : 10.1136/jnnp-2014-309582
Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment, Neurobiology of Aging, vol.32, issue.5, pp.778-90, 2011. ,
DOI : 10.1016/j.neurobiolaging.2009.04.021
Amyloid ??-protein precursor: new clues to the genesis of Alzheimer's disease, Current Opinion in Neurobiology, vol.4, issue.5, pp.708-724, 1994. ,
DOI : 10.1016/0959-4388(94)90014-0
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings, Neurology, vol.78, issue.20, pp.1568-75, 2012. ,
DOI : 10.1212/WNL.0b013e3182563bd0
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant, Human Molecular Genetics, vol.5, issue.7, pp.985-993, 1996. ,
DOI : 10.1093/hmg/5.7.985
Positron Emission Tomography in Evaluation of Dementia, JAMA, vol.286, issue.17, 2001. ,
DOI : 10.1001/jama.286.17.2120
Monoaminergic neuropathology in Alzheimer's disease. Prog Neurobiol, 2016. ,
in patients with dementia, Brain, vol.138, issue.9, pp.2716-2747, 2015. ,
DOI : 10.1093/brain/awv181
Early-onset Alzheimer's disease is associated with a distinct neuropsychological profile, Alzheimer's & Dementia, vol.7, issue.4, pp.101-109, 2012. ,
DOI : 10.1016/j.jalz.2011.05.760
Similar amyloid-?? burden in posterior cortical atrophy and Alzheimer's disease, Brain, vol.134, issue.7, pp.2036-2079, 2011. ,
DOI : 10.1093/brain/awr130
Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.3, 2011. ,
DOI : 10.1136/jnnp.2010.207183
CSF tau markers are correlated with hippocampal volume in Alzheimer's disease, Neurobiology of Aging, vol.33, issue.7, pp.1253-1260 ,
DOI : 10.1016/j.neurobiolaging.2011.02.022
Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS, Current Alzheimer Research, vol.9, issue.9, pp.1050-1058 ,
DOI : 10.2174/156720512803569046
The phenotypical core of Alzheimer-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging,and biomarker study. Alzheimers Dement, pp.786-95786, 2016. ,
Cognitive reserve in ageing and Alzheimer's disease, The Lancet Neurology, vol.11, issue.11, pp.1006-1018, 2012. ,
DOI : 10.1016/S1474-4422(12)70191-6
Variability in cognitive presentation of Alzheimer's disease. Cortex, Feb, vol.44, issue.2, pp.185-95, 2008. ,
Alzheimer CSF biomarkers in routine clinical setting, Acta Neurologica Scandinavica, vol.74, issue.6, pp.416-439 ,
DOI : 10.1111/j.1600-0404.2011.01592.x
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy, Neurology, vol.63, issue.7, pp.1168-74, 2004. ,
DOI : 10.1212/01.WNL.0000140289.18472.15
Cerebrospinal fluid {beta}amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch Neurol, vol.66, issue.3, pp.382-391, 2009. ,
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment, Annals of Neurology, vol.3, issue.4, pp.572-80, 1991. ,
DOI : 10.1002/ana.410300410
Phases of A??-deposition in the human brain and its relevance for the development of AD, Neurology, vol.58, issue.12, pp.1791-800, 2002. ,
DOI : 10.1212/WNL.58.12.1791
Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation, Brain, vol.136, issue.11, pp.3474-88, 2013. ,
DOI : 10.1093/brain/awt266
URL : https://hal.archives-ouvertes.fr/hal-00938644
Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease, J Alzheimers Dis, vol.43, issue.4, pp.1393-402, 2015. ,
From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy, Annals of the New York Academy of Sciences, vol.10, issue.1, pp.240-53, 2000. ,
DOI : 10.1111/j.1749-6632.2000.tb06730.x
Extrapyramidal symptoms and signs in Alzheimer's disease: Pravalence and correlation with the first symptom, American Journal of Alzheimer's Disease and Other Dementias, vol.16, issue.5, pp.268-78, 2001. ,
DOI : 10.1177/153331750101600512
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer???s disease, Acta Neuropathologica, vol.16, issue.2005, pp.213-237, 2016. ,
DOI : 10.1016/j.stem.2015.02.004
Dementia-associated mortality at thirteen years in the NEDICES Cohort Study, J Alzheimers Dis, vol.26, issue.3, pp.543-51, 2011. ,
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study, The Lancet Neurology, vol.8, issue.7, pp.619-646, 2009. ,
DOI : 10.1016/S1474-4422(09)70139-5
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease, Neurology, vol.78, issue.6, pp.379-86, 2012. ,
DOI : 10.1212/WNL.0b013e318245f447
collaborators of GMAJ project. The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers, J Alzheimers Dis, vol.30, issue.4, pp.847-56, 2012. ,
Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers, J Alzheimers Dis, vol.32, issue.1, pp.19-22, 2012. ,
Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, vol.64, issue.2, pp.277-281, 2005. ,
DOI : 10.1212/01.WNL.0000149519.47454.F2
Imaging correlates of posterior cortical atrophy, Neurobiology of Aging, vol.28, issue.7, pp.1051-61, 2007. ,
DOI : 10.1016/j.neurobiolaging.2006.05.026
When loss is gain: reduced presenilin proteolytic function leads to increased A??42/A??40. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO reports, vol.2, issue.2, pp.136-176, 2007. ,
DOI : 10.1038/sj.embor.7400896
Medical Research Council Cognitive Function and Ageing Study collaborators. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up ,
Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study, The Lancet Neurology, vol.14, issue.8, pp.804-817, 2015. ,
DOI : 10.1016/S1474-4422(15)00135-0